44010 Federal Register / Vol. 76, No. 141 / Friday, July 22, 2011 / Notices 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: New collection; Title of 

Information Collection: Communitybased Care Transitions Program (CCTP) 

Implementation and Monitoring; Use: 

The Medicare Community-Based Care 

Transitions Program (CCTP), authorized 

by Section 3026 of the 2010 Affordable 

Care Act, is a major component of the 

Partnership for Patients initiative, one 

goal of which is to decrease preventable 

complications during transition from a 

care setting, such as a hospital, to home, 

community, or another care setting. 

Appendix A contains a copy of the 

relevant portion of the legislation. 

The CCTP will provide funding to test 

models for improving care transitions 

from the hospital to the community for 

high-risk Medicare beneficiaries. The 

Centers for Medicare & Medicaid 

Services (CMS) initiated the CCTP in 

early 2011 and will operate the program 

for five years. Congress has authorized 

$500 million to cover the cost of the 

program. CMS expects that program 

agreements will be in place to authorize 

community-based organizations (CBOs), 

in partnership with acute care hospitals, 

to begin providing care transition 

services in September 2011 and, if 

successful, continue doing so for up to 

five years. The planned collection of a 

participant experience survey is part of 

the implementation and monitoring 

strategy that will review the 

performance of organizations contracted 

to provide transitional care services 

under the CCTP. This clearance package 

seeks approval for the participant 

experience survey. Form Number: CMS– 

10403 (OMB # 0938–New); Frequency: 

Once; Affected Public: Individuals or 

Households; Number of Respondents: 

50,000; Total Annual Responses: 

50,000; Total Annual Hours: 12,500. 

(For policy questions regarding this 

collection contact Juliana Tiongson at 

410–786–0342. For all other issues call 

410–786–1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web site 

at http://www.cms.gov/ 

PaperworkReductionActof1995/PRAL/ 

list.asp#TopOfPage or e-mail your 

request, including your address, phone 

number, OMB number, and CMS 

document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office at 410–786– 

1326. 

In commenting on the proposed 

information collections, please reference 

the document identifier or OMB control 

number. To be assured consideration, 

comments and recommendations must 

be submitted in one of the following 

ways by September 20, 2011: 

1. Electronically. You may submit 

your comments electronically to http:// 

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) accepting comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number, Room C4–26–05, 7500 

Security Boulevard, Baltimore, 

Maryland 21244–1850. 

Dated: July 15, 2011. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2011–18366 Filed 7–21–11; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1355–CN] 

RIN 0938–AQ31 

Medicare Program; Hospice Wage 

Index for Fiscal Year 2012; Correction 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Correction of notice of CMS 

ruling. 

SUMMARY: This document corrects 

technical errors that appeared in the 

notice of CMS ruling published in the 

Federal Register on May 9, 2011 

entitled ‘‘Hospice Wage Index for Fiscal 

Year 2012’’. 

DATES: Effective Date: This document is 

effective on May 9, 2011. 

FOR FURTHER INFORMATION CONTACT: Lori 

Anderson, (410) 786–6190. Randy 

Throndset, (410) 786–0131. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In FR Doc. 2011–10694 of May 9, 

2011 (76 FR 26731), there were 

technical errors that are identified and 

corrected in the Correction of Errors 

section below. The provisions in this 

correction notice are effective as if they 

had been included in the notice of CMS 

ruling published in the Federal Register 

on May 9, 2011. Accordingly, the 

corrections are effective May 9, 2011. 

II. Summary of Errors 

The title of the notice of CMS Ruling 

published in the Federal Register on 

May 9, 2011 (76 FR 26731) was 

incorrectly titled as ‘‘Hospice Wage 

Index for Fiscal Year 2012’’. We note 

that the title should have been ‘‘Hospice 

Appeals for Review of an Overpayment 

Determination’’, to coincide with the 

ruling posted on our CMS Web site on 

April 14, 2011. In addition, the effective 

date of the notice of CMS Ruling was 

incorrectly listed. We are correcting the 

date by changing it from ‘‘April 14, 

2011’’ to ‘‘May 9, 2011’’, the date it was 

published in the Federal Register. 

III. Correction of Errors 

In FR Doc. 2011–10694 of May 9, 

2011 (76 FR 26731), make the following 

corrections: 

1. On page 26731, in the second 

column, in the heading, change the title 

of the notice of CMS ruling from 

‘‘Hospice Wage Index for Fiscal Year 

2012’’ to ‘‘Hospice Appeals for Review 

of an Overpayment Determination’’. 

2. On page 26731, in the second 

column, under ‘‘Dates: Effective Date:’’ 

change the effective date from ‘‘April 

14, 2011’’ to ‘‘May 9, 2011’’. 

Therefore, for reasons noted below, 

we find good cause to waive proposed 

rulemaking and the 30 day delayed 

effective date for the technical 

corrections in this notice. This notice 

merely provides technical corrections to 

the title and the effective date of the 

Notice of CMS ruling that was 

published in the Federal Register on 

May 9, 2011, and does not make 

substantive changes to the notice or to 

the CMS Ruling. Specifically, this 

correction notice corrects the title of the 

notice of CMS ruling from ‘‘Hospice 

Wage Index for Fiscal Year 2012’’ to 

‘‘Hospice Appeals for Review of an 

Overpayment Determination,’’ to 

conform the title of the notice of CMS 

ruling to the title of CMS Ruling 1355– 

R; it also corrects the effective date of 

the notice of CMS ruling from the date 

the Ruling was signed to the date the 

notice of CMS ruling was published in 

the Federal Register. Since this notice 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 76, No. 141 / Friday, July 22, 2011 / Notices 44011 

merely makes technical corrections to 

the title and effective date of the Notice 

of CMS ruling, we believe it is 

unnecessary to undergo further notice 

and comment procedures. In addition, 

we believe it is in the public interest to 

have the correct information and to have 

it as soon as possible and not delay its 

dissemination. For the reasons stated 

above, we find that both notice and 

comment procedures and the 30-day 

delay in effective date for this correction 

document are unnecessary and contrary 

to the public interest. Therefore, we find 

there is good cause to waive notice and 

comment procedures and the 30-day 

delay in effective date for this correction 

document. 

(Catalog of Federal Domestic Assistance 

Program No. 93.773, Medicare—Hospital 

Insurance; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: July 15, 2011. 

Dawn L. Smalls, 

Executive Secretary to the Department. 

[FR Doc. 2011–18424 Filed 7–21–11; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3251–N] 

Medicare Program; Meeting of the 

Medicare Evidence Development and 

Coverage Advisory Committee— 

September 21, 2011 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces that a 

public meeting of the Medicare 

Evidence Development & Coverage 

Advisory Committee (MEDCAC) 

(‘‘Committee’’) will be held on 

Wednesday, September 21, 2011. The 

Committee generally provides advice 

and recommendations concerning the 

adequacy of scientific evidence needed 

to determine whether certain medical 

items and services can be covered under 

the Medicare statute. This meeting will 

focus on the currently available 

evidence regarding antivascular 

endothelial growth factor (anti-VEGF) 

treatment of diabetic macular edema 

(DME). This meeting is open to the 

public in accordance with the Federal 

Advisory Committee Act (5 U.S.C. App. 

2, section 10(a)). 

DATES: Meeting Date: The public 

meeting will be held on Wednesday, 

September 21, 2011 from 7:30 a.m. until 

4:30 p.m., Daylight Saving Time 

(D.S.T.). 

Deadline for Submission of Written 

Comments: Written comments must be 

received at the address specified in the 

ADDRESSES section of this notice by 5 

p.m. D.S.T., Monday, August 22, 2011. 

Once submitted, all comments are final. 

Deadlines for Speaker Registration 

and Presentation Materials: The 

deadline to register to be a speaker and 

to submit PowerPoint presentation 

materials and writings that will be used 

in support of an oral presentation, is 5 

p.m., D.S.T. on Monday, August 22, 

2011. Speakers may register by phone or 

via e-mail by contacting the person 

listed in the FOR FURTHER INFORMATION

CONTACT section of this notice. 

Presentation materials must be received 

at the address specified in the 

ADDRESSES section of this notice. 

Deadline for All Other Attendees 

Registration: Individuals may register 

online at http://www.cms.gov/apps/ 

events/upcomingevents.asp?str

OrderBy=1&type=3 or by phone by 

contacting the person listed in the FOR

FURTHER INFORMATION CONTACT section of 

this notice by 5 p.m. D.S.T., Friday, 

September 16, 2011. 

We will be broadcasting the meeting 

live via Webcast at http://www.cms.gov/ 

live/. 

Deadline for Submitting a Request for 

Special Accommodations: Persons 

attending the meeting who are hearing 

or visually impaired, or have a 

condition that requires special 

assistance or accommodations, are 

asked to contact the Executive Secretary 

as specified in the FOR FURTHER

INFORMATION CONTACT section of this 

notice no later than 5 p.m., D.S.T. 

Friday, September 2, 2011. 

ADDRESSES: Meeting Location: The 

meeting will be held in the main 

auditorium of the Centers for Medicare 

& Medicaid Services, 7500 Security 

Boulevard, Baltimore, MD 21244. 

Submission of Presentations and 

Comments: Presentation materials and 

written comments that will be presented 

at the meeting must be submitted via email to 

MedCACpresentations@cms.hhs.gov or 

by regular mail to the contact listed in 

the FOR FURTHER INFORMATION CONTACT

section of this notice by the date 

specified in the DATES section of this 

notice. 

FOR FURTHER INFORMATION CONTACT: 

Maria Ellis, Executive Secretary for 

MEDCAC, Centers for Medicare & 

Medicaid Services, Office of Clinical 

Standards and Quality, Coverage and 

Analysis Group, S3–02–01, 7500 

Security Boulevard, Baltimore, MD 

21244 or contact Ms. Ellis by phone 

(410–786–0309) or via e-mail at 

Maria.Ellis@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

MEDCAC, formerly known as the 

Medicare Coverage Advisory Committee 

(MCAC), provides advice and 

recommendations to CMS regarding 

clinical issues. (For more information 

on MCAC, see the December 14, 1998 

Federal Register (63 FR 68780).) This 

notice announces the September 21, 

2011, public meeting of the Committee. 

During this meeting, the Committee will 

discuss the currently available evidence 

regarding antivascular endothelial 

growth factor (anti-VEGF) treatment of 

diabetic macular edema (DME). 

Background information about this 

topic, including panel materials, is 

available at http://www.cms.gov/

medicare-coverage-database/indexes/

medcac-meetings-index.aspx?bc=

BAAAAAAAAAAA&. CMS will no 

longer be providing paper copies of the 

handouts for the meeting. Electronic 

copies of all the meeting materials will 

be on the CMS Web site no later than 

2 business days before the meeting. We 

encourage the participation of 

appropriate organizations with expertise 

in the treatment of diabetic retinopathy 

(DR) and DME. 

II. Meeting Format 

This meeting is open to the public. 

The agenda for the day of the meeting 

offers two opportunities for the public 

to participate as either a registered 

scheduled speaker or an unscheduled 

speaker. The Committee will hear oral 

presentations from the registered 

scheduled speakers for approximately 

45 minutes. Time allotted for each 

presentation may be limited. If the 

number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, CMS may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by August 25, 2011. 

Your comments should focus on issues 

specific to the list of topics that we have 

proposed to the Committee. The list of 

research topics to be discussed at the 

meeting will be available on the 

following Web site prior to the meeting: 

http://www.cms.gov/medicare-coveragedatabase/indexes/medcac-meetingsindex.aspx?bc=BAAAAAAAAAAA&. 

We require that you declare at the 

meeting whether you have any financial 

involvement with manufacturers (or 

mstockstill on DSK4VPTVN1PROD with NOTICES